Transitional care coordinator program

Transitional care coordinator program has no effect on 90-day ED visits in humans (6.9% vs 8.7% (p = 0.175)).

“No differences were seen in 90-day ED visits between control and TCC (6.9% vs 8.7%, p = 0.175)”

Human trialpost-discharge following hip fracture surgery90 daysn = 1,569

LVN-led Transitional Care Coordinator Program for Hip Fractures Reduces Mortality

GSA 2025 abstract·31 Dec 2025

Transitional care coordinator program has no effect on 90-day readmissions in humans (23.7% vs. 19.7% (p = 0.06)).

“No differences were seen in 90-day ED visits between control and TCC (6.9% vs 8.7%, p = 0.175) or 90-day readmissions (23.7% vs.19.7%, p = 0.06).”

Human trialpost-discharge following hip fracture surgery90 daysn = 1,569

LVN-led Transitional Care Coordinator Program for Hip Fractures Reduces Mortality

GSA 2025 abstract·31 Dec 2025

Transitional care coordinator program decreases 1-year mortality in humans (11.6% vs. 7.1% (p = 0.003)).

“TCC had lower 90-day (7.8% vs. 3.5%, p = 0.001) and 1-year mortality rates (11.6% vs. 7.1%, p = 0.003).”

Human trialpost-discharge following hip fracture surgery1 yearn = 1,569

LVN-led Transitional Care Coordinator Program for Hip Fractures Reduces Mortality

GSA 2025 abstract·31 Dec 2025

Transitional care coordinator program decreases 90-day mortality in humans (7.8% vs. 3.5% (p = 0.001)).

“TCC had lower 90-day (7.8% vs. 3.5%, p = 0.001) and 1-year mortality rates (11.6% vs. 7.1%, p = 0.003).”

Human trialpost-discharge following hip fracture surgery90 daysn = 1,569

LVN-led Transitional Care Coordinator Program for Hip Fractures Reduces Mortality

GSA 2025 abstract·31 Dec 2025